2026 Annual Meeting | C192 - Neuromuscular Junction Disorders: Myasthenia Gravis, Ocular, and MuSK Myasthenia

Date Wednesday 04/22/26

Time 03:30 PM - 05:30 PM CDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Neelam Goyal, MD, FAAN

Topic(s) Neuromuscular and Clinical Neurophysiology (EMG)

Learning Objectives Participants should understand clinical presentation, diagnosis, and pathophysiology of myasthenia gravis and be able to assess traditional and newer therapies used in the treatment of myasthenia gravis.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
03:30 PM - 04:15 PM CDT	Speaker	Myasthenia Gravis Overview: gMG, OMG, and MuSK MG Stephen Reddel, MBBS, PhD, FRACP
04:15 PM - 05:00 PM CDT	Speaker	Novel Therapies in MG: Complement and FcRn Inhibition Marie Beaudin, MD
05:00 PM - 05:20 PM CDT	Speaker	Clinical Case Discussion Neelam Goyal, MD, FAAN
05:20 PM - 05:30 PM CDT	Q&A	Questions and Answers Neelam Goyal, MD, FAAN

Faculty Disclosures
Neelam Goyal, MD, FAAN	Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Goyal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Goyal has received research support from Argenx.
Stephen Reddel, MBBS, PhD, FRACP	Dr. Reddel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Reddel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Reddel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL. Dr. Reddel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Reddel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Reddel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jannsen. Dr. Reddel has received personal compensation in the range of $5,000-$9,999 for serving as a NIGAC with Australian Government.
Marie Beaudin, MD	Dr. Beaudin has nothing to disclose.

��ɫ��

��ɫ��